Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

ConditionColorectal Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorHelse Stavanger HF

About this trial

* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery

Informed consent to participate

Age ≥18

Disqualifiers

failure to provide written informed consent

Trial population

All patients with colorectal cancer (primary and/or secondary) undergoing surgery for curative intent

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

open and laparoscopic surgery
Procedure/Surgery
Curative surgery for either primary (colorectal cancer, crc) or metastatic CRC (liver surgery)

Treatment groups

1,200 Participants

are divided into 1 treatment group

Group A: open and laparoscopic surgery1 intervention

Trial outcomes

Primary outcomes

Cancer-specific survival

Time from surgery to death of cancer

Time frame

5-years

Secondary outcomes

Recurrence-free survival

Time from surgery to recurrence of cancer

Time frame

3 and 5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Helse Stavanger HF

Lead sponsor

Source ClinicalTrials.gov

Apply now